László Nagy

 nl300x225

Current appointment(s):

Professor of Biochemistry and Molecular Biology
Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary 
(2006-)

Head of Debrecen Clinical Genomics Center  
(2000-)

Adjunct Professor of Pharmacology and Physiology 
Department of Integrative Biology Pharmacology and Physiology 

University of Texas-Houston
, Medical School, Houston Texas, USA 
(1999-)

 International Research Scholar of the Howard Hughes Medical Institute 
(2001-2010)

Wellcome Trust International Senior Research Fellow
(2005-2009)

Contacts:

Office address: 

Department of Biochemistry and Molecular Biology, Research Center for Molecular MedicineMedical and Health Science Center, University of Debrecen, HungaryLife Science Building, Egyetem tér 1., Debrecen, Hungary H-4010

  Phone: +36-52-416432

Fax: +36-52-314989

Skype:

Email: lnagy(at)indi.biochem.dote.hu 

Web site: http://nlab.med.unideb.hu

General information:

Languages:

Hungarian (native)

English (State Exam, Advanced Level A025784 #019455, 2000)

Russian (State Exam, Intermediate Level # A 096533/1987)

 

Academic background:

Retinoid regulated gene expression during differentiation and apoptosis, Molecular analysis of the promoter of the mouse tissue transglutaminase gene 
Thesis for the degree of Ph.D. in Medical Sciences (cell and molecular biology) 
University Medical School of Debrecen, Debrecen, Hungary (1995)  

Ph.D. Student, in Medical Sciences (cell and molecular biology)University Medical School, Debrecen, Hungary(1992-1995)Advisors: Peter J.A. Davies, Ph.D, University of Texas-Houstonand László Fésüs, Ph.D, University Medical School of Debrecen

Programmed cell death in malignant cell lines in vitro
Thesis for the degree of M.D. 
(in Hungarian)
University Medical School of Debrecen, Debrecen, Hungary (1989)  

Medical Student, University Medical School, Debrecen, Hungary(including one year internship in 1991)(1985-1991) 

Scientific background:

Associate Professor of Biochemistry and Molecular Biology,
Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary 
(2000-2006)

Young Investigator of the European Molecular Biology Organization (EMBO) 
(2001-2004)

Assistant Professor of Biochemistry and Molecular Biology,
Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary 
(1999-2000)  

Postdoctoral Associate,
Gene Expression Laboratory, The Salk Institute for Biological Studies , La Jolla, USA 

Special Fellow of the Leukemia Society of America (1998-1999) 
Postdoctoral Fellow of the Howard Hughes Medical Institute (1997-1998) 
Advisor: Ronald M. Evans, Ph.D.

(1996-1999)

Instructor in Biochemistry and Molecular Biology
Department of Biochemistry and Molecular Biology, University medical School of Debrecen, Hungary (1995-1999) 
 

Postdoctoral Fellow,
Department of Pharmacology, University of Texas, Houston, Medical School, USA

Advisor: Peter J.A. Davies M.D., Ph.D.

(1992-1995) 

Research Fellow of the Hungarian Academy of Sciencies, 
Department of Biochemistry, University Medical School, Debrecen, Hungary. 
Advisor: László Fésüs M.D., Ph.D. 
(1991-1992) 

Current memberships in professional societies:

Hungarian Biochemical Society, Member since 1989. 
Hungarian Chamber of Physicians, Member since 1994. 
Society of Pro Scientia Gold Medal Laureates, Member since 1995. 
Endocrine Society (USA), Active Member since 2002 
European Macrophage and Dendritic Cell Society, Member since 2002 
American Society of Biochemistry and Molecular Biology, Member since 2003 
Hungarian Society for Bioinformatics, Founding member, executive committee member since 2006

Awards:

Wellcome Trust International Senior Research Fellow (2005-2009)

Széchenyi Istvan Fellowship (2003-2006)

EMBO Young Investigator (2000-2004)

Howard Hughes Medical Institute International Research Scholar (2000-2010)

Ranked as #5 scientist in 1999 based on the number of highly cited, "Hot papers" published in 1997-1998 (Institute for Scientific Information Hot papers Database)

Széchenyi Professorship (1999-2002) 

Boehringer Ingelheim Research Award (1999)

Cheryl Whitlock/Pathology Prize, Stanford University (1998)

Weszprémi-Prize for Outstanding Academic and Scientific Activity presented by the Rector of the University Medical School of Debrecen (1991)

Outstanding Tutor in Biology University Medical School of Debrecen (1989)

Pro Scientia Gold Medal for Outstanding Scientific Achievements presented by the President of the Hungarian Academy of Sciences (1989)

Publications:

2006

43. Rethi, B., Gogolak, P., Szatmari, I., Veres, A., Nagy, L., Rajnavolgyi, E., Terhorst, C. and Lanyi, A. SLAM/SLAM interactions inhibit CD40 induced production of inflammatory cytokine in monocyte derived dendritic cells Blood 107: 2821-2829 (2006)

 

44. Balint, L. B. and Nagy, L.  Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases Endocrine, Metabolic and Immune Disorders-Drug Targets 6:33-43 (2006) INVITED REVIEW

 

45. Nagy, L., Schüle,R., and Gronemeyer, H.  Twenty years of nuclear receptors (Meeting report) EMBO Reports 7(6): 579-584 (2006)

 

46. Szatmari, I., Rajnavolgyi, E. and Nagy, L.  PPARg, a lipid activated transcription factor as a regulator of dendritic cell function Annals of the New York Academy of Sciences (in press) (2006) INVITED REVIEW

 

47. Szekvolgyi, L., Balint L.,B., Imre, L., Goda, K., Szabo, M., Nagy, L., and Szabo, G., ChIP on-beads: a robust flow-cytometry based method for the evaluation of chromatin immunoprecipitation resultsCytometry (in press) (2006)

 

48. Szeles, L., Torocsik, D. and Nagy, L.  At the crossroad of lipid metabolism and inflammation B.I.F. Futura (Boehringer Ingelheim Funds) 21:79-85 (2006) INVITED REVIEW

 

49. Szatmari, I, Vamosi, G., Brazda, P., Balint L. B., Benko, S., Szeles, L., Jeney, V., Özvegy-Laczka, G., Szanto, A., Barta, E., Balla, J., Sarkadi, B. and Nagy, L. PPARg reguleted ABCG2 expression confers cytoprotection to human dendritic cells Journal of Biological Chemistry 281:23812-23823 (2006)

 

50. PPARg controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells Szatmari, I., Pap, A., Ruehl, R., Ma, J.X., Illarionov, P.A., Besra, G.S., Rajnavolgyi, E., Dezso, B. and Nagy, L.  Journal of Experimental Medicine (in press) (2006)

 

51. Gogolak, P., Rethi, B., Szatmari, I., Lanyi, A., Dezso, B., Nagy, L., Rajnavolgyi, E.  Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARg Blood (in press) (2006)

 2005

35. Szanto, A and Nagy, L.  Retinoids potentiate PPAR-gamma action in differentiation, gene expression and lipid metabolic processes in developing myeloid cells Molecular Pharmacology 67(6):1935-1943 (2005)

 

36. Balint L. B., Szanto, A., Madi, A., Bauer, U-M., Gabor, P., Benko, S., Puskas, L., Davies, P.J.A. and Nagy, L.  Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells Molecular and Cellular Biology 25:5648-5663 (2005)

 

37. Balint L. B., Gabor, P. and Nagy, L.  Genome-wide localization of histone 4 arginine 3 methylation in a differentiation primed myeloid leukemia cell line. Immunobiology 210:141-152 (2005)

 

38. Kappelmayer, J., Simon, A., Katona, E., Szanto, A., Nagy, L., Kiss, A., Kiss, Cs. and Muszbek, L. Flow cytometric detection of intracellular coagulation factor XIII-A: its utilization in the diagnosis and monitoring of monocytic acute myeloid leukemias. Thrombosis and Heamostasis 94(2):454-459 (2005)

 

39. Torocsik, D., Bardos, H., Nagy, L. and Adany, R.  Opposite expression of Factor XIII-A gene in classical and alternative activation of macrophages Cellular and Molecular Life Sciences 62:2132-2139 (2005)

 

40. Nagy, L. and Spiteller, G. Atherosclerosis and lipid peroxidation (Editorial) Molecular Nutrition and Food Research 49: 989-991 (2005) EDITORIAL

 

41. Nagy, L. and Szanto, A. Roles for lipid activated transcription factors Molecular Nutrition and Food Research 49:1072-1074 (2005) INVITED REVIEW

 

42. Djazayeri, K., Szilvassy, Z., Peit, B., Nemeth, J., Nagy, L., Kiss, A., Szabo, B.and Benko, I.  Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment European Journal of Pharmacology 522:122-129 (2005)

2004

31. Nagy, L. and Schwabe J.W.R.  The mechanism of nuclear receptor molecular switch Trends in Biochemical Sciences 29(6):317-324 (2004)

 

32. Szatmari, I., Gogolak, P., Im, S. J., Dezso, B., Rajnavolgyi, E. and Nagy, L.  Activation of PPAR-gamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion Immunity21:95-106 (2004)

 

33. Szanto, A., Benko, S., Szatmari, I., Balint, L.B., Furtos, I., Rühl, R., Molnar, S., Csiba, L., Garuti, R., Calandra, S., Larsson, H., Diczfalusy, U. and Nagy, L.  Transcriptional regulation of human CYP27 integrates retinoid, PPAR and LXR signaling Molecular and Cellular Biology 24(18):8154-8166 (2004)

 

34. Szanto A., Nakar, V., Shen, Q., Uray, I.P., Davies, P.J.A. and Nagy, L.  Retinoid X Receptors: X-ploring their (patho)physiological functions Cell Death and Differentiation 11:S126-S143 (2004) INVITED REVIEW

2003

29. Ahuja, A.S., Szanto, A., Nagy, L. and Davies, P.J.A. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death Journal of Biological Regulators and Homeostatic Agents 17:29-45 (2003) INVITED REVIEW

 

30. Benko S., Love, J.D., Beladi, M., Schwabe, J.W.R. and Nagy, L. Molecular determinants of the balance between co-repressor and co-activator recruitment to the retinoic acid receptor Journal of Biological Chemistry 278: 43797-43806 (2003)

2002

27. Love, J.D., Gooch, J.T., Benko, S., Nagy, L., Chatterjee, V.K.K., Evans,, R.M. and Schwabe, J.W.R. The structural basis for the specificity of retinoid-X-receptor selective agonists: new insights into the role of helix H12. Journal of Biological Chemistry 277(13):11385-11391 (2002)

 

28. Szanto, A and Nagy, L. Lipid sensors in atherosclerosis: The role of nuclear hormone receptors in disease progression B.I.F. Futura (Boehringer Ingelheim Funds) 17:129-136 (2002) INVITED REVIEW

2001

24. Chawla, A., Barak, Y., Nagy, L., Liao, D. Tontonoz, P., and Evans, RM  PPARg dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation Nature Medicine7(1):48-53 (2001)

 

25. Ahuja, HS, Crombie, DL, Boehm, M,Leibowitz, MD, Heyman, RA, Depre, C, Nagy, L., Tontonoz, P and Davies, P.J.A. Tissue specific effects of RXR and PPAR-gamma ligands on metabolic gene expression in diabetic rodents Molecular Pharmacology 59 (4) 765-773 (2001)

 

26. Chawla, A, Boisvert, W.A., Lee, C-H., Laffitte, B., Barak, Y., Joseph, S.B., Nagy, L., Liao, D., Edwards, P.A., Curtiss, L.K., Evans, R.M., and Tontonoz , P. A PPARg-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Molecular Cell 7: 161-171 (2001) 

 2000

21. Love, J.D., Gooch, J.T., Nagy, L., Chatterjee, V.K.K. And Schwabe, J.W.R  Transcriptional repression by nuclear receptors: mechanisms and role in disease Biochem. Soc. Trans. 28: 390-396 (2000) INVITED REVIEW

 

22., Lee, H, Shi, W, Tontonoz, P, Wang, S, Subbanagounder, G., Hedrick, L., Hama, S., Borromeo,C., Evans, RM., Berliner, JA and Nagy, L.  A role for PPARa in oxidized phospholipid induced synthesis of MCP-1 and IL-8 by endothelial cells Circulation Research 87: 516-521 (2000)

 

23., Szegezdi, E, Szondy, Z, Nagy, L., Nemes, Z., Friis, RR., Davies, PJA and Fesus, L.  Divergent signaling pathways regulate the promoter of tissue transglutaminase Cell Death and Differentiation 7(12):1225-1233 (2000)

1999

17. Dupe, V., Ghyselinck, N.B., Thomazy, V., Nagy, L., Davies, P.J.A., Chambon, P. and Mark, M. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopodsDevelopmental Biology 208:30-43 (1999)

 

18. Tontonoz, P and Nagy, L.  Regulation of macrophage gene expression by PPARg: implications for cardiovascular disease Current Opinion in Lipidology 10(6):485-490 (1999) INVITED REVIEW

 

19. Nagy, L.  Molecular mechanisms of nuclear hormone receptor action in health and disease B.I.F. Futura (Boehringer Ingelheim Funds) 14:257-265 (1999) INVITED REVIEW

 

20. Nagy, L., Kao H-Y., Love, JD, , Li, C., Banayo, E., Gooch, JT., Chatterjee, VKK, Evans, RM and Schwabe, JWR  Mechanism of co-repressor binding and release from nuclear hormone receptors Genes and Development 13(24): 3209-3216 (1999)

1998

11. Kuncio, GS., Tsyganskaya, M., Zhu, J,, Liu, S-L., Nagy, L.
Thomazy, VA., Davies, PJA. And Zern, MA 
TNF-a modulates expression of the tissue transglutaminase gene in liver cells American Journal of Physiology 37(2): G240-252 (1998)

 

12. Nagy, L., Thomazy,V.A., Heyman, R.A and Davies, P.J.A. Retinoid-induced apoptosis in normal and neoplastic tissues Cell Death and Differentiation 5(1): 11-19 (1998) INVITED REVIEW

 

13. Nagy, L., Thomazy, V. A, and Davies, P.J.A. A transgenic mouse model for the study of apoptosis during limb development Cell Death and Differentiation 5(1): 126 (1998) INVITED REVIEW

 

14. Lin, J.R., Nagy, L., Satoshi, I., Shao, W., Miller, W., and Evans, R.M. Role of the histone deacetylase complex in Acute Promyelocytic Leukemia Nature 391:811-814 (1998)

 

15. Nagy, L., Tontonoz, P., Alvarez, JGA., Chen, H. and Evans, RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARg Cell 93(2): 229 -240 (1998)

 

16. Tontonoz, P.*, Nagy, L.*, Alvarez, JGA., Thomazy, VA. and Evans, RM. PPARg promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93(2): 241 - 252 (1998) 
* joint first authors

1997

7. Nagy, L., Kao, H-Y., Chakravarti, D., Lin, R.J., Hassig, C.A., 
Ayer, D.E., Schreiber, S.L. and Evans, R.M.  
Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase Cell 89 (3): 373-380 (1997)

 

8. Balajthy, Z., Kedei, N., Nagy, L., Davies P.J.A and Fesus., L. Lack of induction of tissue transglutaminase but activation of the preexisting enzyme in c-myc-induced apoptosis of CHO cells Biochem. Biophys. Res. Comm.236:280-284 (1997)

 

9. Chen, H., Lin, R., Schiltz, L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y. and Evans, R.M. Nuclear receptor co-activator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 Cell 90 (3): 569-580 (1997)

 

10. Nagy, L., Thomazy, A.V., Saydak, M.M., Stein, J.P. and Davies, P.J.A. The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid regulated and apoptosis linked expression Cell Death and Differentiation 4 (7): 534-547 (1997)

 1996

4. Nagy, L., Saydak, M.M., Shipley, N., Lu, S., Basilion, J.P., Yan, Z-H., Syka, P., Chandraratna, RA.S., Stein, J.P., Heyman, R.A. and Davies, P.J.A. Identification and Characterization of a Versatile Retinoid Response Element (Retinoic Acid Response Element/Retinoid X Receptor Response Element) in the Mouse Tissue Transglutaminase Gene Promoter Journal of Biological Chemistry 271 (8): 4355-4365 (1996)

5. Nagy, L., Thomazy, V.A., Heyman, R.A., Chandraratna, R.A.S. and Davies, P.J.A. Retinoid-regulated Expression of BCL-2 and Tissue Transglutaminase During Differentiation and Apoptosis of Human Myeloid Leukemia (HL-60) Cells  Leukemia Research 20 (6): 499-505 (1996)

 

6. Yan, H- Z., Noonan, S., Nagy, L., Davies, P.J.A. and Stein, J.P. Retinoic acid induction of the tissue transglutaminase promoter is mediated by a novel response element Molecular and Cellular Endocrinology 120: 203-212 (1996)

1995

3. Nagy, L., Thomazy, V.A., Shipley, G.L., Fesus, L., Lamph, W., Heyman, R.A., Chandraratna, R.A.S. and Davies, P.J.A. :Activation of Retinoid X Receptors Induces Apoptosis in HL-60 Cell Lines, Molecular and Cellular Biology 15:3540-3551 (1995)

1994

2. Nagy, L., Thomazy,V. and Davies,P.J.A. Tissue Transglutaminase: an effector in physiologic cell death Cancer Bulletin 46:136-140 (1994) INVITED REVIEW   

1991

1. Fesus, L., Nagy, L., Basilion,J. and Davies, P.J.A.  Retinoic Acid Receptor Transcripts in Human Umbilical Vein Endothelial Cells Biochem. Biophys. Res. Comm., 179:32-38 (1991) 

Patents:

1. Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds 
ISSUED ON 5/14/2002 AS U.S. PATENT NO.6,387,673 

2. Use of RAR antagonists as modulators of hormone mediated processes 
ISSUED ON 8/20/2002 AS U.S. PATENT NO. 6,436,993 

3. Treatment of disease states, which result from neoplastic cell proliferation using PPAR-gamma activators and compositions ISSUED ON 11/11/2003 U.S. PATENT NO.6,646,008 

4. Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases ISSUED ON 3/16/2004 US PATENT NO.6,706,762 

5. Novel use of PPAR-gamma modulators and professional APCs manipulated by the same Hungarian Patent Application (May 14th, 2003) P0301358, International PCT/IB2004/050707 (pending) 
International application number: WO 2004/101776 A3 

6. Method for conferring cytoprotection Hungarian Patent Application

(June 19th, 2006)